Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity.

We’ve added new capabilities for encapsia, after we’ve seen increased demand for its use in decentralized trials. Encapsia delivers a complete solution to gather and manage multiple live clinical data sources and apply real-time data management, sophisticated visualizations, analytics, and AI.

Encapsia was designed to address the pain around remote collection, integration, and availability of disparate data. This includes powerful visualizations to provide greater oversight, down to the source data level, to allow immediate action and optimize your trial. In one platform you can collect data via the web or iPad app (EDCHome Visit, and eSource), manage, visualize, and analyze all your clinical data from the portfolio to patient level.

The encapsia team prioritizes enhancements through alignment of client feedback with strategic and environmental changes to the marketplace (e.g., the pandemic). Our project managers and technical consultants operate collaboratively with the client operational teams, holding regular deep-dive governance meetings to support the goals of our clients at both tactical and strategic level.

As biotechnology, pharmaceutical, and medical device companies resumed clinical development in 2020, the new reality necessitated solutions to make managing, interpreting, visualizing, and analyzing data from their clinical programs simpler. This required augmenting and automating clinical research processes to facilitate these decentralized, virtualized, and hybrid trials. Since Q4 2020, we’ve seen a rapid uptake of the encapsia platform, particularly eSource, by sponsors conducting everything from phase I to large scale phase IV studies.

Some of the latest encapsia enhancements include:

  • Ability to add images and files into encapsia EDC – providing evidence to facilitate remote monitoring. Sites use any mobile phone (Android or iOS) to capture images and redact as necessary before upload.
  • EDC supports complex client specific data entry options, together with reports and visualizations directly within the eCRF.
  • Drug supply management and randomization is included through hyper-integration with endpoint Clinical (and other randomization and supply vendors) to offer seamless logistic supply management and randomization to sites.
  • Ability of a user to ‘pin’ their favorite reports/visualizations for immediate access wherever they are in encapsia.
  • Greater options for clients collecting eSource data – more configurable elements, patient mode, and enhanced queries options.
  • New home visit option e.g., for DCT (study nurses visiting patients in their homes).

Dr Timothy Corbett-Clark, Chief Technology Officer, encapsia, commented: “The promise of encapsia is to bring the tech to the data, remove product boundaries, and deliver a holistic, fit for purpose solution that can support the entire development lifecycle. As more data of more types are gleaned from more sources, it all needs to come together for real-time processing during study conduct. That’s what our clients are asking for, and it requires a revolutionary eClinical platform built with the future of clinical research in mind.”

Step Forward with encapsia and let us demonstrate how choosing the right technology can transform your trials of tomorrow.

Learn how encapsia can help you!

To book a no-obligation meeting or demonstration please get in touch by using the contact form below:

Contact us

Latest articles

Why decentralizing clinical trials helps with patient recruitment and retention

Patient recruitment and retention can be a challenge at various points in the clinical development process. Research suggests these challenges can lead to delays of between 1 to 6 months for most clinical trials. More, 11% of clinical research sites…

Read article

What are the four phases of clinical trials?

Clinical trials studying and evaluating new drugs evolve through a number of different stages known as 'phases". Early phase trials examine the safety and dosing of the candidate drugs, while later phase trials are concerned more with safety, tolerability and…

Read article

How to secure quality trial data that delivers a return on investment

The clinical trial landscape has seen unprecedented advances in automated data collection. Cutting-edge technology enables the interrogation and aggregation of vast quantities of data, which brings with it significant challenges in analysis and interpretation. Drug discovery and development is a…

Read article